Provided by Tiger Trade Technology Pte. Ltd.

Aura Biosciences, Inc.

5.68
+0.20003.65%
Post-market: 5.680.00000.00%16:10 EST
Volume:161.91K
Turnover:913.53K
Market Cap:360.70M
PE:-2.99
High:5.75
Open:5.52
Low:5.50
Close:5.48
52wk High:7.73
52wk Low:4.35
Shares:63.50M
Float Shares:36.66M
Volume Ratio:0.59
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8996
EPS(LYR):-1.7506
ROE:-64.26%
ROA:-35.84%
PB:2.30
PE(LYR):-3.24

Loading ...

Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer

TIPRANKS
·
Feb 20

Top Executive Makes a Big Move With Aura Biosciences Stock

TIPRANKS
·
Jan 21

Aura Biosciences Price Target Announced at $13.00/Share by Evercore ISI Group

Dow Jones
·
Nov 26, 2025

Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences

TIPRANKS
·
Nov 26, 2025

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire
·
Nov 25, 2025

Aura Biosciences Q3 Operating Expenses USD 27.906 Million

Reuters
·
Nov 20, 2025

Top Executive Makes Bold Move with Aura Biosciences Stock Sale!

TIPRANKS
·
Nov 18, 2025

Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating

TIPRANKS
·
Nov 14, 2025

Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion

TIPRANKS
·
Nov 14, 2025

Aura Biosciences Unveils Vision for Advancing Organ-Preserving Cancer Treatments

Reuters
·
Nov 13, 2025

Aura Biosciences Q3 EPS $(0.40) Beats $(0.47) Estimate

Benzinga
·
Nov 13, 2025

Aura Biosciences Q3 net loss widens as R&D costs rise

Reuters
·
Nov 13, 2025

BRIEF-Aura Biosciences Q3 Operating Expenses USD 27.906 Million

Reuters
·
Nov 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06, 2025

Aura Biosciences CEO Makes Significant Stock Sale!

TIPRANKS
·
Oct 30, 2025

Aura Biosciences Advances Eye Cancer Treatment with Phase 2 Trial Update

TIPRANKS
·
Oct 28, 2025

Aura Investments’ TECHWISE Study: Unveiling the Impact of Technology on Child Health

TIPRANKS
·
Oct 28, 2025

Aura Biosciences CTO Makes a Bold Move with Stock Sale!

TIPRANKS
·
Oct 17, 2025

Petra Capital Remains a Buy on Aura Energy (AURA)

TIPRANKS
·
Oct 13, 2025

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire
·
Sep 03, 2025